Hollencrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$140K Hold
6,500
0.01% 325
2025
Q1
$108K Buy
6,500
+5,000
+333% +$83.1K ﹤0.01% 353
2024
Q4
$27.5K Hold
1,500
﹤0.01% 587
2024
Q3
$23.1K Hold
1,500
﹤0.01% 641
2024
Q2
$24.4K Hold
1,500
﹤0.01% 606
2024
Q1
$27.7K Hold
1,500
﹤0.01% 581
2023
Q4
$47K Hold
1,500
﹤0.01% 499
2023
Q3
$31.3K Hold
1,500
﹤0.01% 547
2023
Q2
$35.9K Hold
1,500
﹤0.01% 544
2023
Q1
$28.2K Hold
1,500
﹤0.01% 572
2022
Q4
$23.9K Buy
+1,500
New +$23.9K ﹤0.01% 577
2018
Q1
Sell
-7,985
Closed -$241K 332
2017
Q4
$241K Hold
7,985
0.03% 240
2017
Q3
$301K Hold
7,985
0.04% 223
2017
Q2
$222K Sell
7,985
-1,000
-11% -$27.8K 0.03% 254
2017
Q1
$309K Sell
8,985
-600
-6% -$20.6K 0.05% 242
2016
Q4
$277K Sell
9,585
-17
-0.2% -$491 0.04% 226
2016
Q3
$305K Sell
9,602
-3,000
-24% -$95.3K 0.04% 241
2016
Q2
$409K Buy
12,602
+532
+4% +$17.3K 0.06% 213
2016
Q1
$337K Sell
12,070
-2,000
-14% -$55.8K 0.06% 229
2015
Q4
$501K Buy
14,070
+1,017
+8% +$36.2K 0.09% 189
2015
Q3
$432K Buy
13,053
+207
+2% +$6.85K 0.07% 187
2015
Q2
$538K Sell
12,846
-207
-2% -$8.67K 0.08% 179
2015
Q1
$425K Hold
13,053
0.06% 221
2014
Q4
$414K Sell
13,053
-17,932
-58% -$569K 0.05% 239
2014
Q3
$767K Sell
30,985
-19,000
-38% -$470K 0.1% 133
2014
Q2
$1.13M Sell
49,985
-7,000
-12% -$158K 0.15% 107
2014
Q1
$1.39M Hold
56,985
0.21% 94
2013
Q4
$1.42M Buy
+56,985
New +$1.42M 0.23% 86